Pig kidney breakthrough offers hope for patients out of options
NCT ID NCT07224763
Summary
This study is testing a kidney from a genetically modified pig as a transplant for people with end-stage kidney disease who are on dialysis. It's for patients who are not eligible for a human kidney transplant or are unlikely to get one in time. The main goals are to see if the transplant is safe, if the kidney works, and if it helps patients live longer and feel better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New York University Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.